Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes

Obesity

Volumn 17, Issue 10, 2009, Pages 1976-1978

  Pasarica, Magdalena ^a   Tchoukalova, Yourka D ^a   Heilbronn, Leonie K ^a   Fang, Xiaobing ^a   Albu, Jeanine B ^b   Kelley, David E ^c   Smith, Smith R ^a   Ravussin, Eric ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE;

ADIPOCYTE; ARTICLE; BLOOD; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; PHYSIOLOGY; WEIGHT REDUCTION;

ADIPOCYTES; ADIPOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; WEIGHT LOSS;

EID: 70349486032     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.219     Document Type: Article

References (16)

1. Lundgren M, Svensson M, Lindmark S et al. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007;50:625-633.
2. Hotta K, Funahashi T, Bodkin NL et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-1133.
3. Shadid S, Jensen MD. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 2003;26:3148-3152.
4. Blüher M, Wilson-Fritch L, Leszyk J et al. Role of insulin action and cell size on protein expression patterns in adipocytes. J Biol Chem 2004;279:31902-31909.
5. Smith SR, Xie H, Baghian S et al. Pioglitazone changes the distribution of adipocyte size in type 2 diabetics. Adipocytes 2006;2:11-22.
6. Pasarica M, Xie H, Hymel D et al. Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care 2009;32:900-902.
7. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-1033.
8. Wueest S, Rapold RA, Rytka JM, Schoenle EJ, Konrad D. Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice. Diabetologia 2009;52:541-546.
9. Ryan DH, Espeland MA, Foster GD et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24:610-628.
10. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214-E223.
11. Hirsch J, Knittle JL. Cellularity of obese and nonobese human adipose tissue. Fed Proc 1970;29:1516-1521.
12. Bahceci M, Gokalp D, Bahceci S et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 2007;30:210-214.
13. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-2355.
14. de Cabo R, Fürer-Galbán S, Anson RM et al. An in vitro model of caloric restriction. Exp Gerontol 2003;38:631-639.
15. Després J P, Bouchard C, Savard R et al. Level of physical fitness and adipocyte lipolysis in humans. J Appl Physiol 1984;56:1157-1161.
16. Lafontan M, Berlan M, Carpene C. Fat cell adrenoceptors: inter- and intraspecific differences and hormone regulation. Int J Obes 1985; 9 Suppl 1:117-127.